Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow

We found only weak evidence for a reduced risk of HCV reinfection in IDUs who had cleared their previous infection. Further research among those who have cleared infection through antiviral therapy is needed to help inform decisions regarding treatment of IDUs.